| Date Filed | Type | Description |
| 01/13/2023 |
SC 13G
| Empery Asset Management, LP reports a 6.1% stake in RedHill Biopharma Ltd. |
| 01/13/2023 |
SC 13G
| Empery Asset Management, LP reports a 5.1% stake in X4 Pharmaceuticals, Inc. |
| 01/13/2023 |
SC 13G
| Empery Asset Management, LP reports a 10% stake in Volcon, Inc. |
| 01/12/2023 |
SC 13G
| Empery Asset Management, LP reports a 9.6% stake in Permex Petroleum Corp. |
| 01/12/2023 |
SC 13G
| Empery Asset Management, LP reports a 10% stake in Kiromic Biopharma, Inc. |
| 01/12/2023 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Direct Digital Holdings, Inc. |
| 01/12/2023 |
SC 13G/A
| Empery Asset Management, LP reports a 4.7% stake in iSpecimen Inc. |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/18/2022 |
SC 13G
| Empery Asset Management, LP reports a 9.6% stake in Direct Digital Holdings, Inc. |
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/24/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Titan Pharmaceuticals, Inc. |
| 01/24/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 4% stake in Kiora Pharmaceuticals, Inc. |
| 01/24/2022 |
SC 13G
| Empery Asset Management, LP reports a 5.3% stake in iSpecimen Inc. |
| 01/24/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in 1847 Goedeker Inc. |
| 01/24/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Bit Brother Ltd. |
| 01/20/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 0.1% stake in Peraso Inc. |
| 01/20/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 0.4% stake in Pyxis Tankers Inc. |
| 01/20/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Phio Pharmaceuticals Corp. |
| 01/20/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 4.4% stake in Nuwellis, Inc. |
| 01/20/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 2.5% stake in BriaCell Therapeutics Corp. |
| 01/19/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Applied Genetic Technologies Corporation |
| 01/19/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 4.7% stake in enVVeno Medical Corporation |
| 01/19/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 0.4% stake in Hepion Pharmaceuticals, Inc. |
| 01/19/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 2.6% stake in Envirotech Vehicles, Inc. |
| 01/19/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 4% stake in Caladrius Biosciences, Inc. |
| 01/18/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Viveve Medical, Inc. |
| 01/18/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Timber Pharmaceuticals, Inc. |
| 01/18/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Ocuphire Pharma, Inc. |
| 01/18/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 3.3% stake in Castor Maritime Inc. |
| 01/18/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Ring Energy, Inc. |
| 01/13/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 0% stake in Red Cat Holdings, Inc. |
| 01/13/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 0% stake in Kiromic BioPharma, Inc. |
|